Return to Vaccination News Home Page __» Right-click to "open in new window"
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
http://jcm.asm.org/cgi/content/abstract/41/7/3064
|
|
|||||||
Journal of Clinical Microbiology, July 2003, p. 3064-3069,
Vol. 41, No. 7
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.7.3064-3069.2003
Copyright © 2003,
American Society for Microbiology. All
Rights Reserved.
Joshua M. O'Neill,1* Joseph W. St. Geme III,2 David Cutter,2 Elisabeth E. Adderson,3 Juliana Anyanwu,3 Richard F. Jacobs,1 and Gordon E. Schutze1,4
Department of Pediatrics,1 Department of Pathology, University of Arkansas for Medical Sciences/Arkansas Children's Hospital, Little Rock, Arkansas,4 Departments of Pediatrics and Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri,2 Department of Infectious Disease, St. Jude Children's Research Hospital, Memphis, Tennessee3
Received 11 October 2002/ Returned for modification 5 November 2002/ Accepted 6 May 2003
In this study, we reviewed cases of invasive disease due to
nontypeable Haemophilus influenzae among children hospitalized
at Arkansas Children's Hospital from 1993 to 2001. A total of
28 cases were examined, including 21 associated with bacteremia and 4
associated with meningitis. Of the patients examined, 86% were
4 years of age,
and 68% had underlying medical conditions. Characterization of the
bacterial isolates by multilocus sequence type genotyping revealed
significant overall genetic diversity, similar to the diversity in
the general population structure for nontypeable H. influenzae.
However, four separate pairs of isolates were closely related
genetically, a relationship confirmed by pulsed-field gel
electrophoresis and Southern hybridization studies using probes for
the major H. influenzae adhesin genes. These results suggest
that selected strains of nontypeable H. influenzae may have
more invasive potential, especially in young children and patients
with underlying medical conditions. At this point, the specific
factors that contribute to enhanced virulence remain unclear.
* Corresponding author. Mailing address: Arkansas Children's Hospital, 800 Marshall St., Little Rock, AR 72202-3591. Phone: (501) 364-1416. Fax: (501) 364-3551. E-mail: ONeillJoshua@uams.edu.
Journal of Clinical Microbiology, July 2003, p. 3064-3069,
Vol. 41, No. 7
0095-1137/03/$08.00+0 DOI: 10.1128/JCM.41.7.3064-3069.2003
Copyright © 2003,
American Society for Microbiology. All
Rights Reserved.
Copyright © 2003 by the American Society for Microbiology. All rights reserved.
Return to Vaccination News Home Page __» Right-click to "open in new window"
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.